Seagen ^Investors

Seagen is an innovative biotechnology company based in Bothell, Washington, founded in 1998 The company specializes in the development of targeted therapies for cancer treatment, leveraging its proprietary antibody-drug conjugate technology Seagen has garnered significant investment, totaling approximately $49,000,000, to advance its research and development initiatives With a commitment to improving patient outcomes, Seagen continues to expand its portfolio of therapeutic options in oncology The company is recognized for its contributions to the field and its dedication to addressing unmet medical needs